Medela AG   Report issue

For profit
Founded: Baar Switzerland (1961)
Status: No NME R&D (1961)

Organization Overview

First Clinical Trial
2018
NCT03859102
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Medela AG

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 7